Our Approach · VitalMatrix™
The Functional Medicine Matrix is one of the most sophisticated clinical frameworks in modern medicine. VitalMatrix™ adds the layer it has always been missing: the direction of travel, the designation of the driver, and the velocity of the cascade.
See It in PracticeThe Three Principles
Terrain First
VitalMatrix™ scores seven biological nodes, aggregates them into five convergence zones, and identifies which zone is carrying the highest burden. The terrain is the starting point. Symptoms are downstream confirmation, not the primary data source.
Terrain Intelligence Required
Six cascade stacks model the directional relationships between zones. S1 traces gut dysfunction driving thyroid suppression. S2 traces metabolic energy collapse driving hormonal terrain shift. The platform computes the direction so the practitioner can intervene at the origin, not the expression.
Practitioner Authority
VitalMatrix™ is a clinical intelligence platform. It provides terrain intelligence, cascade directionality, and Driver designation. It does not diagnose. It does not prescribe. Every output carries a mandatory Practitioner Clinical Decision section that only the treating clinician completes. The platform amplifies clinical reasoning. It never replaces it.
The Architecture
ZONE 1
N6 Communication and N3 Energy converge. Adrenal, thyroid, and pancreatic terrain. When this zone carries burden, downstream hormonal and cardiovascular cascades accelerate.
ZONE 2
N1 Assimilation, N2 Defence and Repair, and N6 Communication converge. Gut, immune, and brain terrain. The default tiebreaker entry point. Gut restoration is where the cascade loop breaks.
ZONE 3
N5 Transport and N6 Communication converge. Cardiac, pulmonary, and neurovascular terrain. Receives cascade input from both Z2 and Z1. Not ready for composite scoring in Phase 1.
ZONE 4
N4 Biotransformation and Elimination and N2 Defence and Repair converge. Hepatic, lymphatic, and renal terrain. Drives energy via the slow S3 cascade. Not ready for composite scoring in Phase 1.
ZONE 5
N6 Communication, N4 Biotransformation and Elimination, and N3 Energy converge. Androgenic, estrogenic, and progestogenic terrain. Lower activation threshold: 32 on the internal scale.
TERRAINLOCK™
Z2 drives Z1 (S1). Z1 drives Z5 (S2). Z5 drives Z2 (S4). When all three zones are active simultaneously, the cascade becomes self-reinforcing. Z2 gut restoration is the default clinical entry point.
MedTerrain™ Concept
Seven biological nodes. Five convergence zones. One terrain map.
Dr Shahzad Faisal, MBBS, FAAMFM
Practitioner Value
A multi-system analytical output that maps patient burden across seven physiological nodes and five convergence zones, turning complex multi-system data into structured clinical intelligence.
Practitioners using VitalMatrix™ can articulate their clinical methodology with precision and depth. This differentiates them in a crowded market and supports premium private practice positioning.
Every output includes a structured practitioner review section. The platform generates the clinical intelligence record. The practitioner owns and confirms every decision. Fully auditable.
In complex multi-system cases, the practitioner has always had to rely on intuition to sequence clinical priorities. VitalMatrix™ replaces intuition with structured, reproducible terrain analysis.
The structured terrain output gives practitioners the language to explain complex clinical pictures to patients in a way that builds understanding, trust, and therapeutic alliance.
DeltaScan™ compares scored terrain at two time points. It shows which interventions actually shifted the clinical picture. Progress becomes measurable. Outcomes become visible.
The Clinical Gap
The practitioner identifies which nodes are burdened. The practitioner manually estimates which zone is primary. The practitioner infers cascade direction from clinical experience and pattern recognition. The practitioner designates the driver based on intuition refined over years of practice.
This process works. It is how functional medicine has operated since the matrix model was introduced. It is also manual, time-intensive, and impossible to scale beyond what a single practitioner can hold in working memory during a consultation.
Node scoring is computed from structured intake data. Zone convergence is calculated with N6 Communication dampening applied. Cascade directionality is modelled across six stacks with velocity and evidence tier labels. The Driver designation identifies the zone where intervention has the highest downstream impact.
The clinical reasoning is the same. The execution is architectural. The practitioner reviews, adjusts, and decides. The platform ensures that the depth of analysis is consistent for every patient, every time.
The FLINT™ Pipeline
FLINT™ is the processing architecture behind every terrain assessment. Five layers, executed in sequence, each building on the output of the layer before it.
WHERE IS THE BURDEN?
MSQ-71 symptom mapping, ATM timeline data, and MedTerrain™ medication impact feed into seven biological node scores. Each node receives a burden score on the internal 0-100 scale. This is the foundational data layer.
WHICH ZONES ARE CONVERGING?
Node scores aggregate into five NCZ™ zones. N6 Communication is dampened to prevent its cross-zone presence from inflating every zone score. Z5 activates at threshold 32. All others at 40. Near-threshold borderline detection flags zones within 5 internal points of activation.
HOW IS DYSFUNCTION MOVING?
Six cascade relationship stacks model the propagation pathways between active zones. Each stack carries a velocity rating (Fast, Medium, Slow) and an evidence tier (Established, Emerging, or Theoretical). S6 is unidirectional: Z1 to Z3 only. TerrainLock™ detection identifies the self-perpetuating Z2-Z1-Z5 loop.
WHO STARTED IT?
DRD™ designation identifies the highest-burden zone as the Driver and secondary zones as Reactors. The Driver is the intervention target with the greatest downstream cascade impact. Z2 is the default tiebreaker. S4 Theoretical cascades are excluded from the DRD trace.
WHAT SHOULD BE INVESTIGATED?
APEX™ and PRISM™ generate targeted investigation recommendations based on Driver designation and active cascade stacks. Three budget tiers allow the practitioner to match investigation depth to clinical context and patient resources.
WHAT CHANGED?
The sixth stage sits outside the FLINT™ pipeline. DeltaScan™ compares terrain assessments across time, tracking zone score movement, cascade activation changes, and Driver designation shifts between consultations.
Terrain Intelligence
Brain fog. Night waking. Resistant weight. Your patients present with symptoms. VitalMatrix™ maps them to the terrain underneath.
See the Architecture in Action
Dr Faisal walks through the platform using a clinical scenario from your own practice area. Node scoring, zone convergence, cascade directionality, Driver designation: the complete terrain intelligence output, demonstrated on a case you recognise.
Book a Discovery CallExplore Further